PepEvolution
HomePepScore BoardCagrilintide
MetabolicPreliminary grade

Cagrilintide

Novo Nordisk's long-acting amylin analogue for weight management — potent when combined, modest as monotherapy.

Verdict — C · Emerging / Mixed

Amylin analogue with a clean mechanistic rationale and reasonable safety in trials, but the real story is in combination. Standalone approval is unlikely; wait for CagriSema data and a licensed supply path.

Overview

Cagrilintide is a long-acting amylin analogue designed for weekly subcutaneous dosing, studied both as monotherapy and in combination with semaglutide (CagriSema). Phase-2 monotherapy data showed approximately 10-11% weight loss, while the combination shows markedly greater effect. It has not received regulatory approval as a standalone compound, and no verified consumer supply exists.

PepScore Breakdown — the four axes

Evidence

35% weight
61/100

How strong is the published human science?

Human data depth22/40
Regulatory & registry status20/30
Reproducibility & consistency12/20
Mechanism characterized in humans7/10

Sourcing & COA

30% weightOur moat
35/100

Can a buyer obtain an independently-verified, high-purity version? — our proprietary layer.

Independent 3rd-party testing13/35
Verified purity %11/30
COA transparency & batch traceability7/20
Multi-vendor verified availability4/15

Safety & Risk

25% weight
58/100

What is the real-world harm potential?

Documented AEs / toxicity22/40
Contraindication breadth14/25
Regulatory warnings12/20
Therapeutic index / margin10/15

Practicality

10% weight
48/100

How easy is it to actually run a verified version?

Verified-source availability12/35
Cost / value per cycle11/25
Reconstitution & administration16/25
Storage & stability9/15

Sources & Citations

Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.

PepScore51/100 · C
Last gradedJune 28, 2026
Next re-grade triggerRegulatory approval of CagriSema combination would be the most likely path to verified supply.

Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.